Salesforce, Amgen, Honeywell to join Dow Jones Industrial By Reuters

© Reuters. FILE PHOTO: An Amgen sign at the company’s office in South San Francisco


By Noel Randewich

(Reuters) – Shares of (N:), Amgen (O:) and Honeywell International (N:) each surged over 3% in extended trade on Monday after it was announced they would join the as of Aug. 31.

Exxon Mobil (N:), Pfizer (N:) and Raytheon Technologies (N:), which S&P Dow Jones Indices said would leave the 30-component Dow as part of the changes, each fell more than 1%.

S&P Dow Jones Indices, which manages the Dow, said the shakeup was a result of Apple’s (O:) four-for-one stock split, which will take effect the same day.

The drop in Apple’s stock price resulting from its split will reduce its weight within the Dow, along with the overall weight of the technology sector in the Dow. The index is weighted based on the share prices of its components, not on each company’s overall market value. Adding cloud computing heavyweight reduces the decline of tech’s weighting in the Dow.

“The announced changes help offset that reduction. They also help diversify the index by removing overlap between companies of similar scope and adding new types of businesses that better reflect the American economy,” S&P Dow Jones Indices said in a press release. Trading at $217, $245 and $165, respectively, following the announcement, Salesforce, Amgen and Honeywell will have greater weight within the Dow than the companies they are replacing. Exxon last traded at $41.55, Pfizer at $38.22 and Raytheon (NYSE:) was last at $60.06.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button